Abstract:
With the coronavirus disease of 2019 (COVID-19) becoming a full-blown outbreak in Africa, coupled with many
other challenges faced on the African continent, it is apparent that Africa continues to need diagnostics to enable
case identification and recovery to this and future challenges. With the slow vaccination rates across the continent,
reliable diagnostic tests will be in demand, likely for years to come. Thus, access to reliable diagnostic tools to detect
the severe acute respiratory syndrome of the coronavirus-2 (SARS-CoV-2), the virus responsible for COVID-19,
remain a critical pillar to monitor and contain new waves of COVID-19. Increasing the local capacity to manufacture and roll-out vaccines and decentralized COVID-19 testing are paramount for fighting the pandemic in Africa.
